{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T22:19:02Z","timestamp":1759702742365},"publisher-location":"Berlin, Heidelberg","reference-count":176,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642822513"},{"type":"electronic","value":"9783642822490"}],"license":[{"start":{"date-parts":[[1984,1,1]],"date-time":"1984-01-01T00:00:00Z","timestamp":441763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1984]]},"DOI":"10.1007\/978-3-642-82249-0_9","type":"book-chapter","created":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T02:41:30Z","timestamp":1324435290000},"page":"216-239","source":"Crossref","is-referenced-by-count":9,"title":["Acute Myelogenous Leukemia: Current Status of Therapy in Adults"],"prefix":"10.1007","author":[{"given":"K. A.","family":"Foon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. P.","family":"Gale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"9_CR1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1749-6632.1954.tb40023.x","volume":"60","author":"H Tivey","year":"1955","unstructured":"Tivey H (1955) The natural history of untreated acute leukemia. Ann NY Acad Sci 60: 322\u2013358","journal-title":"Ann NY Acad Sci"},{"key":"9_CR2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"JM Bennett","year":"1976","unstructured":"Bennett JM, Catavsky C, Daniel MT et al. (1976) Proposal for the classification of acute leukaemias. Br J Haematol 33: 451\u2013458","journal-title":"Br J Haematol"},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/0003-4819-87-6-740","volume":"87","author":"HR Gralnick","year":"1977","unstructured":"Gralnick HR, Galton DAG, Catovsky D et al. (1977) Classification of acute leukemia. Ann Intern Med 87: 740\u2013753","journal-title":"Ann Intern Med"},{"key":"9_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7326\/0003-4819-92-2-261","volume":"92","author":"HR Gralnick","year":"1980","unstructured":"Gralnick HR (1980) A variant form of hypergranular promyelocytic leukemia (M3). Ann Intern Med 92: 261","journal-title":"Ann Intern Med"},{"key":"9_CR5","volume-title":"acute promyelocytic leukemia: a distinct clinial, ultrastructural and cytogenic entity. Blood 55:253\u2013259","author":"HM Golomb","year":"1980","unstructured":"Golomb HM, Rowley JD, Vardiman JW, Testa JR, Butler A (1980) \u201cMicrogranular\u201d acute promyelocytic leukemia: a distinct clinial, ultrastructural and cytogenic entity. Blood 55:253\u2013259"},{"issue":"5","key":"9_CR6","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1073\/pnas.78.5.3235","volume":"78","author":"PP Major","year":"1981","unstructured":"Major PP, Minden MD, Beardsley GP, Kufe DW (1981) Lethality of human myeloblasts correlates with the incorporation of ara-C into DNA. Proc Natl Acad Sci USA 78 (5): 3235\u20133239","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR7","first-page":"125","volume":"51","author":"HE Skipper","year":"1967","unstructured":"Skipper HE, Schable JM Jr, Wilcox WS (1967) Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. Cancer Chemother Rep 51: 125\u2013141","journal-title":"Cancer Chemother Rep"},{"key":"9_CR8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V32.4.507.507","volume":"32","author":"RR Ellison","year":"1968","unstructured":"Ellison RR, Holland JF, Weil M et al. (1968) Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood 32: 507\u2013523","journal-title":"Blood"},{"key":"9_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(197001)25:1<1::AID-CNCR2820250102>3.0.CO;2-N","volume":"25","author":"JJ Wang","year":"1970","unstructured":"Wang JJ, Selawry OS, Viettr TJ et al. (1970) Prolonged infusion of arabinosyl cytosine in childhood leukemia. Cancer 25: 1\u20136","journal-title":"Cancer"},{"key":"9_CR10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/archinte.1974.00320140098010","volume":"133","author":"GP Bodey","year":"1974","unstructured":"Bodey GP, Coltman CA, Freireich EJ et al. (1974) Chemotherapy of acute leukemia; comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide. Arch Intern Med 133: 260\u2013266","journal-title":"Arch Intern Med"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/archinte.1974.00320140089009","volume":"133","author":"Southwest Oncology Group","year":"1974","unstructured":"Southwest Oncology Group (1974) Cytarabine for acute leukemia in adults: effects of schedule on therapeutic response. Arch Intern Med 133: 251\u2013259","journal-title":"Arch Intern Med"},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/1097-0142(197511)36:5<1560::AID-CNCR2820360504>3.0.CO;2-5","volume":"36","author":"RW Carey","year":"1975","unstructured":"Carey RW, Ribas-Mundo M, Ellison RR et al. (1975) Comparative study of cytosine arabinoside therapy alone and combined with thioguanine mercaptopurine, or daunorubicin in acute myelocytic leukemia. Cancer 36: 1560\u20131566","journal-title":"Cancer"},{"key":"9_CR13","first-page":"138a","volume":"58","author":"AP Early","year":"1981","unstructured":"Early AP, Preisler HD, Slocum H, Rustum YM, Dorn P (1981) High dose cytosine arabinoside (HD-ARAC) for acute leukemia. Blood [Suppl 1] 58: 138a","journal-title":"Blood [Suppl 1]"},{"key":"9_CR14","first-page":"141a","volume":"58","author":"RH Herzig","year":"1981","unstructured":"Herzig RH, Herzig GP, Lazarus HM, Wolff SN, Phillips GL (1981) Successful treatment of patients (PTS) with refractory acute nonlymphocytic leukemia (ANLL) using high-dose cytosine arabinoside (HDAra-C) with and without anthracycline. Blood [Suppl 1] 58: 141a","journal-title":"Blood [Suppl 1]"},{"key":"9_CR15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/1097-0142(197607)38:1<36::AID-CNCR2820380107>3.0.CO;2-M","volume":"38","author":"JA Levi","year":"1976","unstructured":"Levi JA, Wirnik PH (1976) A comparative clinical trial of 5-azacytidine and guanazole in previously treated adults with acute nonlymphocytic leukemia. Cancer 38: 36\u201341","journal-title":"Cancer"},{"key":"9_CR16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood.V48.3.331.331","volume":"48","author":"WR Vogler","year":"1976","unstructured":"Vogler WR, Miller DS, Keller JW (1976) 5-Azacytidine (NSC 102816): A new drug for the treatment of myeloblasts leukemia. Blood 48: 331\u2013337","journal-title":"Blood"},{"key":"9_CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/0003-4819-85-2-237","volume":"85","author":"DD Hoff","year":"1976","unstructured":"Von Hoff DD, Slavik M, Muggia FM (1976) 5-Azacytidine: a new anticancer drug with effectiveness in acute myelogenous leukemia. Ann Intern Med 85: 237\u2013245","journal-title":"Ann Intern Med"},{"key":"9_CR18","first-page":"915","volume":"61","author":"GA Omura","year":"1977","unstructured":"Omura GA (1977) Combination therapy with 5-azacytidine plus beta-2\u2019-deoxythioguanosine in adult acute leukemia. Cancer Treat Rep 61: 915\u2013917","journal-title":"Cancer Treat Rep"},{"key":"9_CR19","first-page":"1599","volume":"61","author":"DA Echo Van","year":"1977","unstructured":"Van Echo DA, Lichenfeld KM, Wiernik PH (1977) Vinblastine, 5-azacytidine and VP-16-213 therapy for previously treated patients with acute nonlymphocytic leukemia. Cancer Treat Rep 61: 1599\u20131602","journal-title":"Cancer Treat Rep"},{"key":"9_CR20","first-page":"437","volume":"61","author":"MA Burgess","year":"1977","unstructured":"Burgess MA, Bodey GP, Minnow RA et al. (1977) Phase I\u2013II evaluation of cyclocytidine. Cancer Treat Rep 61: 437\u201343","journal-title":"Cancer Treat Rep"},{"key":"9_CR21","first-page":"521","volume":"65","author":"P-S Yap","year":"1981","unstructured":"Yap P-S, McCredie KB, Keating MJ et al. (1981) Phase I\u2013II study of 3-deazauridine (NSC 126849) in adults with acute leukemia. Cancer Treat Rep 65: 521\u2013524","journal-title":"Cancer Treat Rep"},{"key":"9_CR22","first-page":"1569","volume":"62","author":"WR Vogler","year":"1978","unstructured":"Vogler WR, Trulock PD (1978) Phase I study of pyrazofurin in refractory acute myelogenous leukemia. Cancer Treat Rep 62: 1569\u20131571","journal-title":"Cancer Treat Rep"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/1097-0142(19811115)48:10<2136::AID-CNCR2820481003>3.0.CO;2-1","volume":"48","author":"R Mertelsmann","year":"1981","unstructured":"Mertelsmann R, Drapkin RL, Gee TS et al. (1981) Treatment of acute myelogenous leukemia in adults: response to 2,2-anhydro-a-\u03b2-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol. Cancer 48: 2136\u20132142","journal-title":"Cancer"},{"key":"9_CR24","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jama.1969.03150200067005","volume":"207","author":"RS Bornstein","year":"1969","unstructured":"Bornstein RS, Theologides A, Kennedy BJ (1969) Daunorubicin in acute myelogenous leukemia in adults. JAMA 207: 1301\u20131306","journal-title":"JAMA"},{"key":"9_CR25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0022-2836(70)90429-8","volume":"54","author":"M Waring","year":"1970","unstructured":"Waring M (1970) Variation in the supercoils in closed circular DNA by binding of antibiotics and drugs: evidence for molecular models involving intercalation. J Mol Biol 54: 247\u2013279","journal-title":"J Mol Biol"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/archinte.1976.03630120041014","volume":"136","author":"M Weil","year":"1976","unstructured":"Weil M, Jacquillat CL, Gemon-Auclerc MF et al. (1976) Acute granulocytic leukemia: treatment of the disease. Arch Intern Med 136: 1389\u20131395","journal-title":"Arch Intern Med"},{"key":"9_CR27","first-page":"921","volume":"33","author":"M Weil","year":"1973","unstructured":"Weil M, Glidewell OJ, Jacquillat C et al. (1973) Daunorubicin in the therapy of acute granulocyte leukemia. Cancer Res 33: 921\u2013928","journal-title":"Cancer Res"},{"key":"9_CR28","first-page":"41","volume":"60","author":"PH Wiernik","year":"1976","unstructured":"Wiernik PH, Schimpf SC, Schiffer CA et al. (1976) Randomized clinical comparison of daunorubicin (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia. Cancer Treat Rep 60: 41\u201353","journal-title":"Cancer Treat Rep"},{"key":"9_CR29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00253012","volume":"6","author":"C Paul","year":"1981","unstructured":"Paul C, Bjorkholm M, Christenson I et al. (1981) Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia. Cancer Chemother Pharmacol 6: 65\u201373","journal-title":"Cancer Chemother Pharmacol"},{"key":"9_CR30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V53.3.455.455","volume":"53","author":"HD Preisler","year":"1979","unstructured":"Preisler HD, Rustum Y, Henderson ES et al. (1979) Treatment of acute nonlymphocytic leukemia: Use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens. Blood 53: 455\u2013464","journal-title":"Blood"},{"key":"9_CR31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM198008283030901","volume":"303","author":"HJ Weinstein","year":"1980","unstructured":"Weinstein HJ, Mayer RJ, Rosenthal DS et al. (1980) Treatment of acute myelogenous leukemia in children and adults. N Engl J Med 303: 473\u2013478","journal-title":"N Engl J Med"},{"key":"9_CR32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM198107163050305","volume":"305","author":"CC Viung","year":"1981","unstructured":"Viung CC, Ozols CF, Myers CE (1981) The anthracycline antineoplastic drugs. N Engl J Med 305: 139\u2013153","journal-title":"N Engl J Med"},{"key":"9_CR33","first-page":"4623","volume":"37","author":"RS Benjamin","year":"1977","unstructured":"Benjamin RS, Keating MJ, McCredie KB et al. (1977) A phase 1 and 2 trial of rubidazone in patients with acute leukemia. Cancer Res 37: 4623\u20134628","journal-title":"Cancer Res"},{"key":"9_CR34","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/1097-0142(197602)37:2<653::AID-CNCR2820370207>3.0.CO;2-Q","volume":"37","author":"C Jacquillat","year":"1976","unstructured":"Jacquillat C, Weil M, Gemon-Auderc MF et al. (1976) Clinical study of rubidazone (22-050 R.P.): a new daunorubicin-derived compound, in 170 patients with acute leukemia and other malignancies. Cancer 37: 653\u2013659","journal-title":"Cancer"},{"key":"9_CR35","first-page":"295","volume":"8","author":"ST Crooke","year":"1977","unstructured":"Crooke ST (1977) A review of carminomycin \u2014 a new anthracycline developed in the USSR. J Med 8: 295\u2013316","journal-title":"J Med"},{"key":"9_CR36","first-page":"756","volume":"22","author":"FE Fainshtein","year":"1977","unstructured":"Fainshtein FE, Kovaleva LG, Vakhrusheva MV et al. (1977) Carminomycin in the treatment of adult patients with acute leukemia. Antibiotiki 22: 756\u2013758","journal-title":"Antibiotiki"},{"key":"9_CR37","first-page":"191","volume":"22","author":"RP Warrell Jr","year":"1981","unstructured":"Warrell RP Jr, Arlin Z, Gee T et al. (1981) Phase I-II evaluation of aclacinomycin in acute leukemia. Am Assoc Cancer Res 22: 191","journal-title":"Am Assoc Cancer Res"},{"key":"9_CR38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0305-7372(80)80033-8","volume":"7","author":"K Yamada","year":"1980","unstructured":"Yamada K, Nakamura T, Tsuruno T et al. (1980) A phase II study of aclacinomycin in acute leukemia in adults. Cancer Treat Rev 7: 177\u2013182","journal-title":"Cancer Treat Rev"},{"key":"9_CR39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1749-6632.1954.tb40008.x","volume":"60","author":"GH Hitchings","year":"1954","unstructured":"Hitchings GH, Elion GB (1954) The chemistry and biochemistry of purine analogs. Ann NY Acad Sci 60: 195\u2013199","journal-title":"Ann NY Acad Sci"},{"issue":"431","key":"9_CR40","first-page":"454","volume":"18","author":"E Frei III","year":"1961","unstructured":"Frei E III, Freireich EJ, Gehan G et al. (1961) Studies of sequential and combination antimetabolite therapy in acute leukemia: 6-mercaptopurine and methotrexate. Blood 18: 431, 454","journal-title":"Blood"},{"key":"9_CR41","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood.V8.11.965.965","volume":"8","author":"JH Burchenal","year":"1953","unstructured":"Burchenal JH, Murphy ML, Ellison RR et al. (1953) Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases. Blood 8: 965\u2013999","journal-title":"Blood"},{"key":"9_CR42","first-page":"1379","volume":"61","author":"GA Omura","year":"1977","unstructured":"Omura GA, Vogler WR, Smalley RV et al. (1977) Phase II study of \u03b2-2\u2019-deoxytheoguanosine in adult acute leukemia. Cancer Treat Rep 61: 1379\u20131381","journal-title":"Cancer Treat Rep"},{"key":"9_CR43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-93-1-17","volume":"93","author":"SS Legha","year":"1980","unstructured":"Legha SS, Keating MJ, Zander A et al. (1980) 4\u2019-(acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia. Ann Intern Med 93: 17\u201321","journal-title":"Ann Intern Med"},{"key":"9_CR44","first-page":"477","volume":"21","author":"DA Echo Van","year":"1980","unstructured":"Van Echo DA, Markus SD, Schimpff SC, Wiernik PH (1980) A phase II trial of 4\u2019-(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in adult relapsed acute leukemia. Proc AM Assoc Can Res 21: 477","journal-title":"Proc AM Assoc Can Res"},{"key":"9_CR45","first-page":"148a","volume":"58","author":"PA Paciucci","year":"1981","unstructured":"Paciucci PA, Ohnuma T, Ambinder EP et al. (1981) Effects of mitoxantrone (dehydroxyan- thracenedine dehydrochloride) in patients with refractory acute leukemia. Blood [Suppl 1] 58: 148a","journal-title":"Blood [Suppl 1]"},{"key":"9_CR46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/pgmj.52.604.66","volume":"52","author":"IC Smith","year":"1976","unstructured":"Smith IC, Gerken MC, Clink HM et al. (1976) VP-16-213 in acute myelogenous leukaemia. Postgrad Med J 52: 66\u201370","journal-title":"Postgrad Med J"},{"key":"9_CR47","first-page":"1231","volume":"63","author":"PA Radice","year":"1979","unstructured":"Radice PA, Bunn PA Jr, Ihde DC (1979) Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkins lymphomas, and other malignancies. Cancer Treat Rep 63: 1231\u20131239","journal-title":"Cancer Treat Rep"},{"key":"9_CR48","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/1097-0142(197410)34:4<985::AID-CNCR2820340402>3.0.CO;2-U","volume":"34","author":"G Math\u00e9","year":"1974","unstructured":"Math\u00e9 G, Schwarzenberg L, Pouillart P et al. (1974) Two epidophyllotoxin derivatives, VM 26 and VP 16-213, in the treatment of leukemias, hematosorcomas and lymphomas. Cancer 34: 985\u2013992","journal-title":"Cancer"},{"key":"9_CR49","first-page":"325","volume":"3","author":"DA Echo Van","year":"1980","unstructured":"Van Echo DA, Wiernik PH, Aisner J (1980) High-dose VP 16-213 (NSC141540) for the treatment of patients with previously treated acute leukemia. Cancer Clin Trials 3: 325\u2013328","journal-title":"Cancer Clin Trials"},{"key":"9_CR50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.3.5873.199","volume":"3","author":"European Organization for Research on the Treatment of Cancer, Clinical Screening Group","year":"1973","unstructured":"European Organization for Research on the Treatment of Cancer, Clinical Screening Group (1973) Epipodophyllotoxin VP 16213 in treatment of acute leukaemias, haematosarcomas, and solid tumors. Br Med J 3: 199\u2013202","journal-title":"Br Med J"},{"key":"9_CR51","first-page":"1599","volume":"61","author":"PA Echo Van","year":"1977","unstructured":"Van Echo PA, Lichtenfeld KM, Wiernik PH (1977) Vinblastine (NSC-49848), 5-azacytidine (NSC 102816) and VP 16-213 (NSC 141540) in previously treated patients with acute nonlymphocytic leukemia. Cancer Treat Rep 61: 1599\u20131602","journal-title":"Cancer Treat Rep"},{"key":"9_CR52","doi-asserted-by":"crossref","unstructured":"Hurd DD, Peterson BA, Bloomfield CD (1981) 4\u2019-(9-acridinylamino) methanesulfon-m-anisidide (AMSA), VP 16-213 (VP), cytosine arabinoside (ARA-C), and G-thioguanine (GTG) in the treatment of relapsed and refractory acute nonlymphocytic leukemia (ANLL). Blood [Suppl 1] 58: 142a","DOI":"10.1002\/mpo.2950090308"},{"key":"9_CR53","first-page":"1853","volume":"63","author":"TW Griffin","year":"1979","unstructured":"Griffin TW, Lister TA, Rybak ME et al. (1979) Treatment of acute nonlymphocytic leukemia with neocarzinostatin. Cancer Treat Rep 63: 1853\u20131856","journal-title":"Cancer Treat Rep"},{"key":"9_CR54","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood.V18.4.431.431","volume":"18","author":"E Frei III","year":"1961","unstructured":"Frei E III, Freireich EH, Gehan G et al. (1961) Studies of sequential and combination antimetabolist therapy in acute leukemia: 6-mercaptopurine and methotrexate. Blood 18: 431\u2013454","journal-title":"Blood"},{"key":"9_CR55","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/1097-0142(196708)20:8<1221::AID-CNCR2820200806>3.0.CO;2-0","volume":"20","author":"WR Vogler","year":"1967","unstructured":"Vogler WR, Huguley CM Jr, Rundles RW (1967) Comparison of methotrexate with 6-mercaptopurine-prednisone in treatment of acute leukemia in adults. Cancer 20: 1221\u20131226","journal-title":"Cancer"},{"key":"9_CR56","first-page":"167","volume":"16","author":"B Hoogstraten","year":"1962","unstructured":"Hoogstraten B (1962) Cyclophosphamide (cytoxan) in acute leukemia. Cancer Chemother Rep 16: 167\u2013171","journal-title":"Cancer Chemother Rep"},{"key":"9_CR57","first-page":"279","volume":"25","author":"B Clarkson","year":"1970","unstructured":"Clarkson B, Krakoff J, Burchenal J et al. (1970) Clinical results of treatment with E. Coli L-asparaginase in adults with leukemia, lymphoma and solid tumors. Cancer 25: 279\u2013305","journal-title":"E. Coli L-asparaginase in adults with leukemia, lymphoma and solid tumors. Cancer"},{"key":"9_CR58","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev.me.21.020170.002245","volume":"21","author":"RL Capizzi","year":"1980","unstructured":"Capizzi RL, Bertino JR, Handschumacher RE (1980) L-Asparaginase. Annu Rev Med 21: 433\u2013444","journal-title":"L-Asparaginase. Annu Rev Med"},{"key":"9_CR59","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/bmj.1.5500.1383","volume":"1","author":"Medical Research Council","year":"1966","unstructured":"Medical Research Council (1966) Treatment of acute leukemia in adults: comparison of steroid and mercaptopurine therapy, alone and in conjunction. Br Med J 1: 1383\u20131389","journal-title":"Br Med J"},{"key":"9_CR60","first-page":"1310","volume":"33","author":"RC Conti De","year":"1973","unstructured":"De Conti RC, Toftness BR, Lange RC et al. (1973) Clinical and pharmacological studies with cis-diamminedichloroplatinum(II). Cancer Res 33: 1310\u20131315","journal-title":"Cancer Res"},{"key":"9_CR61","doi-asserted-by":"crossref","first-page":"803","DOI":"10.7326\/0003-4819-86-6-803","volume":"86","author":"M Rozenweig","year":"1977","unstructured":"Rozenweig M, von Hoff DD, Slavik M et al. (1977) C\/s-diamminedichloroplatinum(II): a new anticancer drug. Ann Intern Med 86: 803\u2013812","journal-title":"Ann Intern Med"},{"key":"9_CR62","first-page":"23","volume":"11","author":"NO Hill","year":"1981","unstructured":"Hill NO, Pardue A, Khan A et al. (1981) Phase I human leukocyte interferon trials in cancer leukemia. J Clin Hematol Oncol 11: 23\u201325","journal-title":"J Clin Hematol Oncol"},{"key":"9_CR63","first-page":"1645","volume":"39","author":"AS Levine","year":"1979","unstructured":"Levine AS, Sivulich M, Wiernik PH, Levy HB (1979) Initial clinical trials in cancer patients of polyriboinosinic - polyribocy tidy lie acid stabilized with poly-1-lysine, in carboxymethylcellu- lose [poly(ICLC)], a highly effective interferon inducer. Cancer Res 39: 1645\u20131650","journal-title":"Cancer Res"},{"key":"9_CR64","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/1097-0142(197508)36:2+<775::AID-CNCR2820360824>3.0.CO;2-V","volume":"36","author":"BD Clarkson","year":"1975","unstructured":"Clarkson BD, Dowling MD, Gee TS et al. (1975) Treatment of acute leukaemia in adults. Cancer 36: 775\u2013795","journal-title":"Cancer"},{"key":"9_CR65","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2141.1974.tb06805.x","volume":"27","author":"Medical Research Council","year":"1974","unstructured":"Medical Research Council (1974) Treatment of acute myeloid leukemia with daunorubicin, cytosine arabinoside, mercyptopurine, L-asparaginase, prednisone and thioguanine: results of treatment with five multipledrug schedules. Br J Haematol 27: 373\u2013389","journal-title":"Br J Haematol"},{"key":"9_CR66","first-page":"255","volume-title":"Acute leukemia group B studies, therapy of acute leukemia","author":"HJ Wallace","year":"1975","unstructured":"Wallace HJ, Holland JF, Glidewell OJ et al. (1975) Therapy of acute myelocytic leukemia. In: Madelli F, Amadori S, Mariani G (eds) Acute leukemia group B studies, therapy of acute leukemia. Minerva Medica, Turin, pp 255\u2013269"},{"key":"9_CR67","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/1097-0142(197704)39:4<1387::AID-CNCR2820390406>3.0.CO;2-Y","volume":"39","author":"JP Lewis","year":"1977","unstructured":"Lewis JP, Linman HW, Marshall GJ et al. (1977) Randomized clinical trial of cytosine arabinoside and 6-thioguanine in remission induction and consolidation of adult nonlymphocytic acute leukemia. Cancer 39: 1387\u20131396","journal-title":"Cancer"},{"key":"9_CR68","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archinte.1976.03630120029012","volume":"136","author":"JF Holland","year":"1976","unstructured":"Holland JF, Glidewell O, Ellison RR et al. (1976) Acute myelocytic leukemia. Arch Intern Med 136: 1377\u20131381","journal-title":"Arch Intern Med"},{"key":"9_CR69","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-94-6-753","volume":"94","author":"RP Gale","year":"1981","unstructured":"Gale RP, Foon KA, Cline MJ, Zighelboim J (1981) Intensive chemotherapy for acute myelogenous leukemia. Ann Intern Med 94: 753\u2013757","journal-title":"Ann Intern Med"},{"key":"9_CR70","first-page":"1131","volume":"59","author":"H Glucksberg","year":"1975","unstructured":"Glucksberg H, Buckner DE, Fefer A et al. (1975) Combination chemotherapy for acute nonlymphoblastic leukemia in adults. Cancer Chemother Rep 59: 1131\u20131137","journal-title":"Cancer Chemother Rep"},{"key":"9_CR71","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bjc.1977.260","volume":"36","author":"JKH Rees","year":"1977","unstructured":"Rees JKH, Sandler RM, Challener J, Hayhoe FGJ (1977) Treatment of acute myeloid leukemia with a triple cytotoxic regimen: DAT. Br J Cancer 36: 770\u2013776","journal-title":"Br J Cancer"},{"key":"9_CR72","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/1097-0142(19800815)46:4<663::AID-CNCR2820460406>3.0.CO;2-9","volume":"46","author":"BA Peterson","year":"1980","unstructured":"Peterson BA, Bloomfield CD, Bosi GJ, Gibbs G, Malloy M (1980) Intensive fivedrug combination chemotherapy for adult acute-non-lymphocytic leukemia. Cancer 46: 663\u2013668","journal-title":"Cancer"},{"key":"9_CR73","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0002-9343(82)90858-0","volume":"72","author":"KA Foon","year":"1982","unstructured":"Foon KA, Gale RP (1982) Controversies in the therapy of acute myelogenous leukemia. Am J Med 72: 963\u2013979","journal-title":"Am J Med"},{"key":"9_CR74","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0609.1979.tb02683.x","volume":"23","author":"Finnish Leukemia Group","year":"1979","unstructured":"Finnish Leukemia Group (1979) The effect of thioguanine in a combination of daunorubicine [sic], cytyrabine and prednisone in the treatment of acute leukemia in adults. Scand J Hematol 23: 124\u2013128","journal-title":"Scand J Hematol"},{"key":"9_CR75","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1182\/blood.V58.6.1203.1203","volume":"58","author":"KR Rai","year":"1981","unstructured":"Rai KR, Holland JR, Glidewell OJ et al. (1981) Treatment of acute myelocytic leukemia: A study by Cancer and Leukemia Group B. Blood 58: 1203\u20131212","journal-title":"Blood"},{"key":"9_CR76","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/1097-0142(197810)42:4<1747::AID-CNCR2820420413>3.0.CO;2-T","volume":"42","author":"RE Slavin","year":"1978","unstructured":"Slavin RE, Dias MA, Saral R (1978) Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols. A clinical-pathologic study of 33 patients. Cancer 42: 1747\u20131759","journal-title":"Cancer"},{"key":"9_CR77","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V60.2.454.454","volume":"60","author":"J Yates","year":"1982","unstructured":"Yates J, Gledeucll O, Wiernik P et al. (1982) Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: A CALGB study. Blood 60: 454\u2013462","journal-title":"Blood"},{"key":"9_CR78","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/1097-0142(19801015)46:8<1731::AID-CNCR2820460805>3.0.CO;2-I","volume":"46","author":"BS Shaikh","year":"1980","unstructured":"Shaikh BS, Doghtery JB, Hamilton RW et al. (1980) Selective use of daunorubicin for remission-induction chemotherapy in acute non-lymphoblastic leukemia. Cancer 46: 1731\u20131734","journal-title":"Cancer"},{"key":"9_CR79","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/archinte.1979.03630480057018","volume":"139","author":"EJ Saponara","year":"1979","unstructured":"Saponara EJ, Rothenberg SP, Villamena D (1979) Cytarabine and thioguanine for acute nonlymphocytic leukemia. Another look. Arch Intern Med 139: 1277\u20131280","journal-title":"Arch Intern Med"},{"key":"9_CR80","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(77)90315-1","volume":"62","author":"DD Hoff Von","year":"1977","unstructured":"Von Hoff DD, Rozencweig M, Layard M, Slavik M, Muggia FM (1977) Daunomycin induced cardiotoxicity in children and adults. A review of 110 cases. Am J Med 62: 200\u2013208","journal-title":"Am J Med"},{"key":"9_CR81","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1056\/NEJM197508212930807","volume":"293","author":"AM Mauer","year":"1975","unstructured":"Mauer AM (1975) Cell kinetics and practical consequences for therapy of acute leukemia. N Engl J Med 293: 389\u2013393","journal-title":"N Engl J Med"},{"key":"9_CR82","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/1097-0142(19800301)45:5<859::AID-CNCR2820450506>3.0.CO;2-Z","volume":"45","author":"WP Vaughan","year":"1980","unstructured":"Vaughan WP, Karls JE, Burke PJ (1980) Long chemotherapy-free remissions after single-cycle times-sequential chemotherapy for acute myelocytic leukemia. Cancer 45: 859\u2013865","journal-title":"Cancer"},{"key":"9_CR83","volume-title":"Proc Am Soc Clin Oncol (to be published)","author":"J Zighelboim","year":"1982","unstructured":"Zighelboim J, Foon K, Yale C, Gale RP (1982) Treatment of acute myelogenous leukemia with intensive induction and consolidation chemotherapy. Proc Am Soc Clin Oncol (to be published)"},{"key":"9_CR84","first-page":"271","volume":"22","author":"D Urbanitz","year":"1981","unstructured":"Urbanitz D, Hiddemann W, Van de Loo J, Buchner TH (1981) Intensive and rapid remission induction in acute non-lymphocytic leukemia (ANLL) followed by consolidation without maintenance therapy. Proc Am Assoc Cancer Res 22: 271","journal-title":"Intensive and rapid remission induction in acute non-lymphocytic leukemia (ANLL) followed by consolidation without maintenance therapy. Proc Am Assoc Cancer Res"},{"key":"9_CR85","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/archinte.1978.03630340016009","volume":"138","author":"CA Coltman","year":"1978","unstructured":"Coltman CA, Bodey GP, Hewlett JJ (1978) Chemotherapy of acute leukemia. A comparison of vincristine, cytarabine, and prednisone alone and in combination with cyclophosphamide or daunorubicin. Arch Intern Med 138: 1342\u20131348","journal-title":"Arch Intern Med"},{"key":"9_CR86","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/1097-0142(19800115)45:2<280::AID-CNCR2820450213>3.0.CO;2-O","volume":"45","author":"M Eppinger-Helft","year":"1980","unstructured":"Eppinger-Helft M, Pavlovsky S, Hidalgo G et al. (1980) Chemoimmunotherapy with Corynebacterium parvum in acute myelocytic leukemia. Cancer 45: 280\u2013284","journal-title":"Cancer"},{"key":"9_CR87","first-page":"232","volume":"22","author":"H Glucksberg","year":"1981","unstructured":"Glucksberg H, Cheever M, Fefer A, Forewell V, Thomas ED (1981) Intensification therapy in acute nonlymphocytic leukemia (ANL) in adults. Proc AACR\/ASCO 22: 232","journal-title":"Proc AACR\/ASCO"},{"key":"9_CR88","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1002\/1097-0142(19810415)47:8<1937::AID-CNCR2820470804>3.0.CO;2-G","volume":"47","author":"GP Bodey","year":"1978","unstructured":"Bodey GP, Freireich EJ, McCredie KG et al. (1978) Prolonged remissions in adults with acute leukemia following late intensification chemotherapy and immunotherapy. Cancer 47: 1937\u20131945","journal-title":"Cancer"},{"key":"9_CR89","first-page":"1455","volume":"66","author":"RJ Mayer","year":"1982","unstructured":"Mayer RJ, Weinstein JH, Coral FS, Rosenthal DS, Frei E (1982) The role of intensive post-induction chemotherapy in the management of patients with acute myelogenous leukemia. Cancer Treat Rep 66: 1455\u20131462","journal-title":"Cancer Treat Rep"},{"key":"9_CR90","volume-title":"Present status of trials in man","author":"WD Terry","year":"1978","unstructured":"Terry WD, Windhorst D (1978) Immunotherapy of cancer. Present status of trials in man. Raven, New York"},{"key":"9_CR91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00199523","volume":"9","author":"WR Vogler","year":"1980","unstructured":"Vogler WR (1980) Results of randomized trials of immunotherapy for acute leukemia. Cancer Immunol Immunother 9: 15\u201321","journal-title":"Cancer Immunol Immunother"},{"key":"9_CR92","unstructured":"Foon KA, Smalley RV, Gale RP (to be published) The role of immunotherapy in acute myelogenous leukemia"},{"key":"9_CR93","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(74)90070-1","volume":"2","author":"JU Gutterman","year":"1974","unstructured":"Gutterman JU, Hersh EM, Rodriquez B et al. (1974) Chemoimmunotherapy of adult acute leukaemia: prolongation of remission in myeloblasts leukaemia with BCG. Lancet 2: 1405\u20131409","journal-title":"Lancet"},{"key":"9_CR94","first-page":"353","volume-title":"Immunotherapy of cancer: present status of trials in man","author":"JF Holland","year":"1978","unstructured":"Holland JF, Bekesi JG (1978) Comparison of chemotherapy with chemotherapy plus VCN-treated cells in acute myelocytic leukemia. In: Terry WD, Windhorst D (eds) Immunotherapy of cancer: present status of trials in man. Raven, New York, pp 353\u2013374"},{"key":"9_CR95","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/bjc.1973.162","volume":"28","author":"RL Powles","year":"1973","unstructured":"Powles RL, Crowther D, Bateman CJT (1973) Immunotherapy for acute myelogenous leukemia. Br J Cancer 28: 365\u2013376","journal-title":"Br J Cancer"},{"key":"9_CR96","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00205783","volume":"3","author":"W Vogler","year":"1978","unstructured":"Vogler W, Bartolucci AA, Omura GA et al. (1978) A randomized clinical trial of remission induction, consolidation and chemo-immunotherapy maintenance in adult acute myeloblasts leukemia. Cancer Immunol Immunother 3: 163\u2013170","journal-title":"Cancer Immunol Immunother"},{"key":"9_CR97","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00199260","volume":"11","author":"WR Vogler","year":"1981","unstructured":"Vogler WR, Gordon DS, Smalley RV et al. (1981) Serial immunologic assessment during a randomized trial of chemoimmunotherapy in acute myelogenous leukemia. A southeastern cancer study group clinical trial. Cancer Immunol Immunother 11: 97\u2013107","journal-title":"Cancer Immunol Immunother"},{"key":"9_CR98","unstructured":"Omura GA, Vogler WR, Lefante J et al. (to be published) Treatment of acute myelogenous leukemia: Influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapy. Cancer"},{"key":"9_CR99","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2141.1980.tb07159.x","volume":"45","author":"JA Whittaker","year":"1980","unstructured":"Whittaker JA, Bailey-Wood R, Hutchins S (1980) Active immunotherapy for treatment of acute myelogenous leukemia: report of two controlled trials. Br J Hematol 45: 389\u2013400","journal-title":"Br J Hematol"},{"key":"9_CR100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0609.1978.tb02493.x","volume":"21","author":"H Vuvan","year":"1978","unstructured":"Vuvan H, Fiere D, Doillon M et al. (1978) B.C.G. therapy in acute nonlymphoid leukaemias. Scand J Haematol 21: 40\u201346","journal-title":"Scand J Haematol"},{"key":"9_CR101","first-page":"181","volume":"15","author":"S Murphy","year":"1978","unstructured":"Murphy S, Hersh E (1978) Immunotherapy of leukemia and lymphoma. Semin Haematol 15: 181\u2013203","journal-title":"Semin Haematol"},{"key":"9_CR102","first-page":"387","volume-title":"Immunotherapy of cancer: present status of trials in man","author":"JS Hewlett","year":"1977","unstructured":"Hewlett JS, Belcerzak S, Gutterman J et al. (1977) Remission induction in adult acute leukemia by 10-day continuous intravenous infusion of Ara-C plus oncovin and prednisone. Maintenance with and without immunotherapy. In: Terry WD, Windhurst D (eds) Immunotherapy of cancer: present status of trials in man. Raven, New York, pp 387\u2013391"},{"key":"9_CR103","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/bjc.1979.254","volume":"40","author":"GP Summerfield","year":"1979","unstructured":"Summerfield GP, Gibbs TJ, Bellingham AJ (1979) Immunotherapy using BCG during remission induction and as the sole form of maintenance in acute myeloid leukemia. Br J Cancer 40: 736\u2013742","journal-title":"Br J Cancer"},{"key":"9_CR104","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0145-2126(81)90115-6","volume":"5","author":"F Mandelli","year":"1981","unstructured":"Mandelli F, Amadori S, Dini E et al. (1981) Randomized clinical trial of immunotherapy and androgenotherapy for remission maintenance in acute non-lymphocytic leukemia. Leuk Res 5: 447\u2013452","journal-title":"Leuk Res"},{"key":"9_CR105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/bjc.1977.38","volume":"35","author":"RL Powles","year":"1977","unstructured":"Powles RL, Russell J, Lister TA (1977) Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2-1\/1 years after entry of the last patient. Br J Cancer 35: 265\u2013272","journal-title":"Br J Cancer"},{"key":"9_CR106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1978.1","volume":"37","author":"Medical Research Council","year":"1978","unstructured":"Medical Research Council (1978) Immunotherapy of acute myeloid leukaemia. Br J Cancer 37: 1\u201311","journal-title":"Br J Cancer"},{"key":"9_CR107","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00204737","volume":"4","author":"CH Lindemalm","year":"1978","unstructured":"Lindemalm CH, S-N, Killander A, Bjorkholm M et al. (1978) Adjuvant immunotherapy in acute nonlymphocytic leukemia. Cancer Immunol Immunother 4: 179\u2013183","journal-title":"Cancer Immunol Immunother"},{"key":"9_CR108","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/bjc.1980.60","volume":"41","author":"SR Zuhrie","year":"1980","unstructured":"Zuhrie SR, Harris R, Freeman CB, et al. (1980) Immunotherapy alone vs no maintenance treatment in acute myelogenous leukemia. Br J Cancer 41: 372\u2013377","journal-title":"Br J Cancer"},{"key":"9_CR109","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/1097-0142(19801115)46:10<2142::AID-CNCR2820461005>3.0.CO;2-J","volume":"46","author":"TA Lister","year":"1980","unstructured":"Lister TA, Whitehouse JMA, Oliver RTD et al. (1980) Chemotherapy and immunotherapy for acute myelogenous leukemia. Cancer 46: 2142\u20132148","journal-title":"Cancer"},{"key":"9_CR110","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(77)90549-9","volume":"2","author":"RL Powles","year":"1977","unstructured":"Powles RL, Selby PJ, Jones DR et al. (1977) Maintenance of remission in acute myelogenous leukemia by a mixture of BCG and irradiated leukemia cells. Lancet 2: 1107\u20131109","journal-title":"Lancet"},{"key":"9_CR111","first-page":"127","volume":"7","author":"RL Baehner","year":"1979","unstructured":"Baehner RL, Bernstein ID, Sather H et al. (1979) Improved remission induction rate with D-ZAPO but unimproved remission duration with addition of immunotherapy to chemotherapy in previously untreated children with ANLL Med Pediatr Oncol 7: 127\u2013139","journal-title":"Improved remission induction rate with D-ZAPO but unimproved remission duration with addition of immunotherapy to chemotherapy in previously untreated children with ANLL Med Pediatr Oncol"},{"key":"9_CR112","first-page":"667","volume":"13","author":"G Izak","year":"1977","unstructured":"Izak G, Stupp Y, Manny N et al. (1977) The immune response in acute myelogenous leukemia. Effect of methanol extraction residue fraction of tubercle bacilli (MER) on T and B cell functions and their relation to the course of the disease. Isr J Med Sci 13: 667\u2013693","journal-title":"Isr J Med Sci"},{"key":"9_CR113","first-page":"355","volume-title":"Immunotherapy of cancer: present status of trials in man","author":"C Sauter","year":"1978","unstructured":"Sauter C, Cavalli F, Lindenmann J et al. (1978) Viral oncolysis: its application in maintenance treatment of acute myelogenous leukemia. In: Terry WD, Windhorst D (eds) Immunotherapy of cancer: present status of trials in man. Raven, New York, pp 355\u2013363"},{"key":"9_CR114","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-79-4-541","volume":"79","author":"DM Dawson","year":"1979","unstructured":"Dawson DM, Rosenthal DS, Moloney WC (1979) Neurological complications of acute leukemia in adults: changing rate. Ann Intern Med 79: 541\u2013544","journal-title":"Ann Intern Med"},{"key":"9_CR115","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/1097-0142(197709)40:3<1304::AID-CNCR2820400346>3.0.CO;2-V","volume":"40","author":"IP Law","year":"1977","unstructured":"Law IP, Blom J (1977) Adult acute leukemia: frequency of central nervous system involvement in long term survivors. Cancer 40: 1304\u20131306","journal-title":"Cancer"},{"key":"9_CR116","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/1097-0142(19810101)47:1<184::AID-CNCR2820470130>3.0.CO;2-M","volume":"47","author":"DJ Steward","year":"1981","unstructured":"Steward DJ, Keating MJ, McCredie KB et al. (1981) Natural history of central nervous system acute leukemia in adults. Cancer 47: 184\u2013196","journal-title":"Cancer"},{"key":"9_CR117","first-page":"341","volume":"18","author":"BA Peterson","year":"1977","unstructured":"Peterson BA, Bloomfield CD (1977) Asymptomatic central nervous system (CNS) leukemia in adults with acute non-lymphocytic leukemia (ANLL) in extended remission. Proc AACR\/ASCO 18: 341","journal-title":"Proc AACR\/ASCO"},{"key":"9_CR118","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/1097-0142(197901)43:1<83::AID-CNCR2820430112>3.0.CO;2-S","volume":"43","author":"L Wolff","year":"1979","unstructured":"Wolff L, Zighelboim J, Gale RP (1979) Paraplegia following intrathecal cytosine arabinoside. Cancer 43: 83\u201385","journal-title":"Cancer"},{"key":"9_CR119","first-page":"172","volume":"22","author":"ZA Arlin","year":"1981","unstructured":"Arlin ZA, Gee TS, Kempin SJ et al. (1981) Treatment of adult nonlymphoblastic leukemia (ANLL) with AMSA in combination with cytosine arabinoside (ARA-C) and 6-thioguanine (6TG) A AT. Proc Assoc Cancer Res 22: 172","journal-title":"Proc Assoc Cancer Res"},{"key":"9_CR120","first-page":"143a","volume":"58","author":"SB Kahn","year":"1981","unstructured":"Kahn SB, Conroy JR, Bulova S, Biodsky J (1981) Acridinyl anisidide (AMSA) (NSC 249992) and 5-azacytidine (AZA) (NSC 102816) therapy of acute leukemia. Blood [Suppl 1] 58: 143a","journal-title":"Blood [Suppl 1]"},{"key":"9_CR121","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O","volume":"44","author":"SA Rudnick","year":"1979","unstructured":"Rudnick SA, Cadman ED, Capizzi RL et al. (1979) High dose cytosine arabinoside (HDARAC) in refractory acute leukemia. Cancer 44: 1189\u20131193","journal-title":"Cancer"},{"key":"9_CR122","first-page":"142a","volume":"58","author":"JD Hines","year":"1981","unstructured":"Hines JD, Oken MM, Mazza J, Keller A, Glick J (1981) High dose cytosine arabinoside (ARA-C) and M-AMSA in refractory acute non-lymphocytic leukemia. Blood [Suppl 1] 58: 142a","journal-title":"Blood [Suppl 1]"},{"key":"9_CR123","first-page":"476","volume":"22","author":"TS Herman","year":"1981","unstructured":"Herman TS, Durie BGM, Hutter J (1981) Treatment of refractory acute myelogenous leukemia (AML) with vincristine, high dose methotrexate, l,3-bis-(2-choroethyl)-l-nitrosurea (BCNU), cyclophosphamide and methylglyoxal bis(guanylhydrazone) (MGBG). Proc AACR\/ASCO 22: 476","journal-title":"Proc AACR\/ASCO"},{"key":"9_CR124","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0145-2126(81)90099-0","volume":"5","author":"BA Peterson","year":"1981","unstructured":"Peterson BA, Bloomfield CD (1981) Re-induction of complete remissions in adults with acute non-lymphocytic leukemia. Leuk Res 5: 81\u201388","journal-title":"Leuk Res"},{"key":"9_CR125","first-page":"167","volume":"10","author":"RP Gale","year":"1978","unstructured":"Gale RP (1978) Approach to leukemic relapse following bone marrow transplantation. Transplant Proc 10: 167\u2013172","journal-title":"Transplant Proc"},{"key":"9_CR126","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood.V49.4.511.511","volume":"49","author":"ED Thomas","year":"1977","unstructured":"Thomas ED, Buckner CD, Banaji M et al. (1977) One hundred patients with acute leukemia treated with chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49: 511\u2013533","journal-title":"Blood"},{"key":"9_CR127","first-page":"1197","volume":"2","author":"UCLA Bone-Marrow Transplantation Team","year":"1977","unstructured":"UCLA Bone-Marrow Transplantation Team (1977) Bone-marrow transplantation in acute leukaemia. Lancet 2: 1197\u20131200","journal-title":"Lancet"},{"key":"9_CR128","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJM197406202902501","volume":"290","author":"A Fefer","year":"1974","unstructured":"Fefer A, Einstein AB, Thomas ED et al. (1974) Bone-marrow transplantation for hematologic neoplasia in 16 patients with identical twins. N Engl J Med 290: 1389\u20131393","journal-title":"N Engl J Med"},{"key":"9_CR129","first-page":"121","volume":"9","author":"ED Thomas","year":"1981","unstructured":"Thomas ED, Buckner CD, Clift RA et al. (1981) Marrow transplantation for patients with leukemia. Exp Hematol [Suppl 9] 9: 121","journal-title":"Exp Hematol [Suppl 9]"},{"key":"9_CR130","first-page":"125","volume":"9","author":"RP Gale","year":"1981","unstructured":"Gale RP (1981) Bone marrow transplantation for leukemia in remission. Exp Hematol [Suppl 9] 9: 125","journal-title":"Exp Hematol [Suppl 9]"},{"key":"9_CR131","first-page":"213","volume":"41","author":"GR Morgenstern","year":"1980","unstructured":"Morgenstern GR (1980) Allogeneic bone marrow transplantation for acute leukaemia. Experience in 55 patients. Blut 41: 213\u2013215","journal-title":"Blut"},{"key":"9_CR132","first-page":"208","volume":"41","author":"FE Zwaan","year":"1980","unstructured":"Zwaan FE (1980) Bone marrow transplantation for acute leukaemia in remission \u2014 European results. Blut 41: 208\u2013213","journal-title":"Blut"},{"key":"9_CR133","first-page":"143","volume":"22","author":"J Kersey","year":"1981","unstructured":"Kersey J, Ramsey N, Kim T et al. (1981) Bone marrow transplantation (BMT) in first remission in young patients with acute non-lymphocytic leukemia (ANLL). Proc AACR\/ASCO 22: 143","journal-title":"Proc AACR\/ASCO"},{"key":"9_CR134","first-page":"216","volume":"41","author":"FE Zwaan","year":"1980","unstructured":"Zwaan FE, Jansen J, Noordijk EM (1980) Bone marrow transplantation in acute myeloid leukaemia (AML) during first remission: the Leiden experience. Blut 41: 216\u2013220","journal-title":"Blut"},{"key":"9_CR135","first-page":"125","volume":"9","author":"R Dinsmore","year":"1981","unstructured":"Dinsmore R, Shane B, Kapoor N et al. (1981) A randomized trial of bone marrow transplantation (BMT) versus chemotherapy (CT) maintenance for acute myelogenous leukemia in first remission: preliminary results. Exp Hematol [Suppl 9] 9: 125","journal-title":"Exp Hematol [Suppl 9]"},{"key":"9_CR136","first-page":"124","volume":"9","author":"B Speck","year":"1981","unstructured":"Speck B, Gratwohl A, Nissen C et al. (1981) Further experience with cylosporin -A in allogeneic bone marrow transplantation. Exp Hematol [Suppl 9] 9: 124","journal-title":"Exp Hematol [Suppl 9]"},{"key":"9_CR137","first-page":"220","volume":"41","author":"P Mannoni","year":"1980","unstructured":"Mannoni P, Vernant JP, Rodet M et al. (1980) Marrow transplantation for acute nonlymphoblastic leukemia in first remission. Blut 41: 220\u2013225","journal-title":"Blut"},{"key":"9_CR138","first-page":"124","volume":"9","author":"KG Blume","year":"1981","unstructured":"Blume KG, Forman SJ, Spruce WE et al. (1981) Bone marrow transplantion (BMT) for acute leukemia. Exp Hematol [Suppl 9] 9: 124","journal-title":"Exp Hematol [Suppl 9]"},{"key":"9_CR139","volume-title":"Boca Raton","author":"JP Okunewick","year":"1980","unstructured":"Okunewick JP, Meredith RF (1980) Graft-versus-leukemia in man and animal models. CRC, Boca Raton"},{"key":"9_CR140","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","volume":"300","author":"PL Weiden","year":"1979","unstructured":"Weiden PL, Flournoy N, Thomas ED et al. (1979) Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 300: 1068\u20131073","journal-title":"N Engl J Med"},{"key":"9_CR141","first-page":"1","volume-title":"Graft-versus-leukemia in man and animal models","author":"R Mclntyre","year":"1981","unstructured":"Mclntyre R, Gale RP (1981) Relationship between graft-versus-leukemia and graft-versus-host in man \u2014 UCLA experience. In: Okunewick JP, Meredith RF (eds) Graft-versus-leukemia in man and animal models. CRC, Boca Raton, pp 1\u20139"},{"key":"9_CR142","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM198106183042507","volume":"304","author":"PL Weiden","year":"1981","unstructured":"Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED and the Seattle Marrow Transplant Team (1981) Antileukemic effect of chronic graft-versushost disease. Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 304: 1529\u20131533","journal-title":"N Engl J Med"},{"key":"9_CR143","first-page":"1924","volume":"11","author":"JA Hansen","year":"1979","unstructured":"Hansen JA, Clift RA, Thomas ED, Buckner CD, Mickelson EM, Storb R (1979) Histocompatibility and marrow transplantation. Transplant Proc 11: 1924\u20131929","journal-title":"Transplant Proc"},{"key":"9_CR144","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJM198009043031007","volume":"303","author":"JA Hansen","year":"1980","unstructured":"Hansen JA, Clift RA, Thomas ED, Buckner CD, Storb R, Giblett ER (1980) Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 303: 565\u2013567","journal-title":"N Engl J Med"},{"key":"9_CR145","first-page":"177","volume":"10","author":"PR Graze","year":"1978","unstructured":"Graze PR, Gale RP (1978) Autotransplantation for leukemia and solid tumors. Transplant Proc 10: 177\u2013184","journal-title":"Transplant Proc"},{"key":"9_CR146","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00007890-197809000-00008","volume":"26","author":"KA Dicke","year":"1978","unstructured":"Dicke KA, McCredie KB, Spitzer G et al. (1978) Autologous bone marrow transplantation in patients with adult acute leukemia in relapse. Transplantation 26: 169\u2013173","journal-title":"Transplantation"},{"key":"9_CR147","first-page":"164","volume":"7","author":"JR Wells","year":"1979","unstructured":"Wells JR, Billing R, Herzog P et al. (1979) Autotransplantation after in vitro immunotherapy of lymphoblastic leukemia. Exp Hematol [Suppl] 7: 164\u2013169","journal-title":"Exp Hematol [Suppl]"},{"key":"9_CR148","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0140-6736(80)91787-0","volume":"1","author":"B Netzel","year":"1980","unstructured":"Netzel B, Rodt H, Haas RJ et al. (1980) Immunological conditioning of bone marrow for autotransplantation in childhood acute lymphoblastic leukemia. Lancet 1: 1330\u20131332","journal-title":"Lancet"},{"key":"9_CR149","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(82)91686-5","volume":"2","author":"J Ritz","year":"1982","unstructured":"Ritz J, Sallan SE, Bast RC et al. (1982) Autologous bone marrow transplantation in CALLA positive acute lymphoblastic leukemia after in vitro treatment with J5 monoclonal antibody and complement. Lancet 2: 60\u201363","journal-title":"Lancet"},{"key":"9_CR150","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ajh.2830070412","volume":"7","author":"J Groopman","year":"1979","unstructured":"Groopman J, Ellman L (1979) Acute promyelocytic leukemia. Am J Hematol 7: 395\u2013408","journal-title":"Am J Hematol"},{"key":"9_CR151","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2141.1973.tb05730.x","volume":"24","author":"HR Gralnick","year":"1973","unstructured":"Gralnick HR, Abrell E (1973) Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukemia. Br J Haematol 24: 89\u201399","journal-title":"Br J Haematol"},{"key":"9_CR152","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajh.2830080403","volume":"8","author":"PA Daly","year":"1980","unstructured":"Daly PA, Shiffer CA, Wiernik PH (1980) Acute promyelocytic leukemia: Clincal management of 15 patients. Am J Hematol 8: 347\u2013359","journal-title":"Am J Hematol"},{"key":"9_CR153","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.V41.4.489.489","volume":"41","author":"J Bernard","year":"1973","unstructured":"Bernard J, Weil M, Boiron M, Jacquillarc, Flandrin G, Geman M-F (1973) Acute promyelocytic leukemia: Results of treatment by daunorubicin. Blood 41: 489\u2013496","journal-title":"Blood"},{"key":"9_CR154","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/archinte.1978.03630360059024","volume":"138","author":"AJ Collins","year":"1978","unstructured":"Collins AJ, Bloomfiled CD, Paterson BA, McKenna RW, Edison JR (1978) Acute progranulocytic leukemia. Management of the coagulopathy diromg daunorubicin-prednisone induction. Arch Intern Med 138: 1677\u20131680","journal-title":"Arch Intern Med"},{"key":"9_CR155","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/1097-0142(197709)40:3<1300::AID-CNCR2820400345>3.0.CO;2-9","volume":"40","author":"JS Lilleyman","year":"1977","unstructured":"Lilleyman JS, Hill AS, Anderton KJ (1977) Consequences of acute myelogenous leukemia in early pregnancy. Cancer 40: 1300\u20131303","journal-title":"Cancer"},{"key":"9_CR156","first-page":"369","volume":"63","author":"J Pizzuyo","year":"1979","unstructured":"Pizzuyo J, Aviles A, Noviega L, Niz J, Morales M, Ramero F (1979) Treatment of acute leukemia during pregnancy: presentation of nine cases. Cancer Treat Rep 63: 369\u2013371","journal-title":"Cancer Treat Rep"},{"key":"9_CR157","first-page":"369","volume":"63","author":"KC Daney","year":"1979","unstructured":"Daney KC, Kraemer KG, Shepard TH (1979) Combination chemotherapy for acute myelocytic leukemia during pregnancy: three case reports. Cancer Treat Rep 63: 369\u2013371","journal-title":"Cancer Treat Rep"},{"key":"9_CR158","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/mpo.2950040112","volume":"4","author":"RJ Meyer","year":"1978","unstructured":"Meyer RJ, Guttner J, Truog P, Ambinder EP, Holland JH (1978) Therapeutic leukopheresis of acute myelo-monocytic leukemia in pregnancy. Med Pediatr Oncol 4: 77\u201381","journal-title":"Med Pediatr Oncol"},{"key":"9_CR159","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0308-2261(21)00201-0","volume":"9","author":"F Rosner","year":"1980","unstructured":"Rosner F, Grunwald HW (1980) Cytotoxic drugs and leukaemogenesis. Clin Haematol 9: 663\u2013681","journal-title":"Clin Haematol"},{"key":"9_CR160","doi-asserted-by":"crossref","unstructured":"Anonymous (1977) Therapy-linked leukaemia. Lancet 1: 519\u2013520 (editorial)","DOI":"10.1016\/S0140-6736(77)91377-0"},{"key":"9_CR161","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJM197707282970411","volume":"197","author":"BA Chabner","year":"1977","unstructured":"Chabner BA (1977) Second neoplasm: a complication of cancer chemotherapy. N Engl J Med 197: 213\u2013215","journal-title":"N Engl J Med"},{"key":"9_CR162","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1056\/NEJM197707282970402","volume":"297","author":"RR Reimer","year":"1977","unstructured":"Reimer RR, Hoover R, Graumeni JF Jr et al. (1977) Acute leukemia after alkylating agent therapy of ovarian cancer. N Engl J Med 297: 177\u2013181","journal-title":"N Engl J Med"},{"key":"9_CR163","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/1097-0142(197709)40:3<1280::AID-CNCR2820400343>3.0.CO;2-A","volume":"40","author":"ED Cadman","year":"1977","unstructured":"Cadman ED, Capizzo RL, Bertino JR (1977) Acute non-lymphocytic leukemia: A delayed complication of Hodgkin\u2019s disease therapy. Analysis of 109 cases. Cancer 40: 1280\u20131296","journal-title":"Cancer"},{"key":"9_CR164","first-page":"483","volume":"22","author":"WD Vaughan","year":"1981","unstructured":"Vaughan WD, Karp JE, Burke PJ (1981) Effective chemotherapy of acute myelocytic leukemia (AML) occurring after alkylating agent therapy (AAT) or radiation therapy (RT) for prior malignancy. Proc AACR\/ASCO 22: 483","journal-title":"Proc AACR\/ASCO"},{"key":"9_CR165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.7326\/0003-4819-93-2-347","volume":"93","author":"HP Koeffler","year":"1980","unstructured":"Koeffler HP, Golde DW (1980) Human preleukemia. Ann Intern Med 93: 347\u2013353","journal-title":"Ann Intern Med"},{"key":"9_CR166","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-93-1-133","volume":"93","author":"CD Bloomfield","year":"1980","unstructured":"Bloomfield CD (1980) Treatment of acute nonlymphocytic leukemia \u2014 1980. Ann Intern Med 93: 133\u2013135","journal-title":"Ann Intern Med"},{"key":"9_CR167","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM197912203012501","volume":"301","author":"MA Baker","year":"1979","unstructured":"Baker MA, Falk JA, Carter WH, Taub RN and the Toronto Leukemic Study Group (1979) Early diagnosis of relapse in acute myeloblasts leukemia. N Engl J Med 301: 1353\u20131357","journal-title":"N Engl J Med"},{"key":"9_CR168","first-page":"475","volume":"303","author":"WN Hittleman","year":"1980","unstructured":"Hittleman WN, Broussard LC, Dosik G, McCredie KB (1980) Predicting relapse of human leukemia by means of premature chromosome condensation. N Engl J Med 303: 475\u2013484","journal-title":"N Engl J Med"},{"key":"9_CR169","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/274535a0","volume":"274","author":"L Sachs","year":"1978","unstructured":"Sachs L (1978) Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature 274: 535\u2013539","journal-title":"Nature"},{"key":"9_CR170","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1126\/science.306682","volume":"200","author":"HP Koeffler","year":"1978","unstructured":"Koeffler HP, Golde DW (1978) Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science 200: 1153\u20131154","journal-title":"Science"},{"key":"9_CR171","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1073\/pnas.76.10.5158","volume":"76","author":"J Loten","year":"1979","unstructured":"Loten J, Sachs L (1979) Regulation of normal differentiation in mouse and human myeloid leukemia cells by phorbol esters and the mechanism of tumor promoter. Proc Natl Acad Sci USA 76: 5158","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR172","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1073\/pnas.76.6.2779","volume":"76","author":"G Rovera","year":"1979","unstructured":"Rovera G, Santole D, Damsky C (1979) Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with phorbol diester. Proc Natl Acad Sci USA 76: 2779","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR173","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1073\/pnas.75.5.2458","volume":"75","author":"SJ Collins","year":"1978","unstructured":"Collins SJ, Ruscetti RW, Gallagher RE, Gallo RC (1978) Terminal differentiation of human promyelocytic leukemia cells induced by dimethylsulfoxide and other polar compounds. Proc Natl Acad Sci USA 75: 2458\u20132462","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR174","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1084\/jem.149.4.969","volume":"149","author":"SJ Collins","year":"1979","unstructured":"Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC (1979) Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med 149: 969\u2013974","journal-title":"J Exp Med"},{"key":"9_CR175","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1182\/blood.V57.6.1000.1000","volume":"57","author":"TR Breitman","year":"1981","unstructured":"Breitman TR, Collins SJ, Keene BR (1981) Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 57: 1000\u20131004","journal-title":"Blood"},{"key":"9_CR176","first-page":"3211","volume":"41","author":"Y Honma","year":"1981","unstructured":"Honma Y, Kasukabe T, Hozumi M, Tsushima S, Nomura H (1981) Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyl-lysophospholipids. Cancer Res 41: 3211\u20133216","journal-title":"Cancer Res"}],"container-title":["Recent Results in Cancer Research","Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-82249-0_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T02:45:34Z","timestamp":1713235534000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-82249-0_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984]]},"ISBN":["9783642822513","9783642822490"],"references-count":176,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-82249-0_9","relation":{},"ISSN":["0080-0015"],"issn-type":[{"type":"print","value":"0080-0015"}],"subject":[],"published":{"date-parts":[[1984]]}}}